EU science report highlights recent progress in use of non-animal methods
Europe makes progress, but a plan for humane and human-relevant science is still needed to drive real change
- Celebrates progress made in re-using chemical safety test data for similar substances to avoid further animal tests. ECVAM has also been working with international partners to develop guidelines on moving to computer-based methods for safety testing such as skin allergy or carcinogenicity tests.
- Confirms advancements have been made in the development of non-animal methods for quality control tests of human and veterinary vaccines.
- Updates ECVAM’s progress in developing guidance on moving away from quality control tests using animals to a ‘consistency-based strategy’ (ensuring that each vaccine batch is similar or ‘consistent’ to a previously tested batch) that use non-animal methods.
- Details ECVAM’s reviews of the use of non-animal methods in seven major disease research areas including breast cancer, brain disorders and heart disease.
- Outlines ECVAM’s work to increase efforts in the development and validation of organ-on-chip methods and plans for a European roadmap for the standardization of organ-on-a-chip technologies.